MedTrace Logo

High-density Mapping-guided bOx Isolation and subsTrate Ablation

NCT03998956 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2019-07-01

No results posted yet for this study

Summary

This study evaluates the efficacy of high-density mapping guided atrial substrate ablation for persistent atrial fibrillation. 1/5 of the patients with persistent atrial fibrillation undergo pulmonary veins isolation, 2/5 of them pulmonary veins and box isolation while others undergo atrial substrate ablation apart from pulmonary veins and box isolation.

Conditions

Interventions

PROCEDURE

CPVI

Circumferential PV isolation only

PROCEDURE

CPVI+BOX

Circumferential PV and BOX isolation

PROCEDURE

CPVI+BOX+SUB

Atrial substrate ablation apart from circumferential PV and BOX isolation

Sponsors & Collaborators

  • The Third Xiangya Hospital of Central South University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-01
Primary Completion
2021-08-31
Completion
2021-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03998956 on ClinicalTrials.gov